By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for plozasiran for the treatment of familial chylomycronemia syndrome (FCS), with a Prescription Drug User Fee Act … Read more
The Louisiana Citizens Property Insurance Corporation (Louisiana Citizens) Board of Directors voted last week to end the 1.36% assessment it makes on all residential and commercial property insurance policies in the state in April of this year. The assessment, which goes toward paying off bonds for debt Louisiana Citizens incurred from claims for hurricanes Katrina … Read more
An important date is approaching: Sunday, Jan. 19, also known as Edgar Allan Poe’s birthday. I’m just kidding. That heartbeat in the floorboards? It’s TikTok’s. The Supreme Court is considering the constitutionality of a law that would ban TikTok in the U.S. If the court upholds the law, it will go into effect on Jan. 19. … Read more
New Orleans officials projected confidence in their security plans as the city prepares to host the Super Bowl and Mardi Gras in the aftermath of a terror attack that killed 14 people on New Year’s Day and questions linger over security lapses. “We know that we’re ready but guess what? We’re wanting to double down … Read more
Analysts at Keefe, Bruyette & Woods (KBW) are the second group to say that the returns generated from catastrophe reinsurance risk underwriting and capital allocation can remain strong, just so long as the industry remains disciplined on attachments, terms and conditions.It’s taken a while for it to become clearer that the real driver of the … Read more
